Splenectomy as adjunctive therapy for immune-mediated thrombocytopenia and hemolytic anemia in the dog.

Splenectomy was done in 9 dogs having immune-mediated hematologic disorders refractory to medical therapy. These disorders were immune-mediated thrombocytopenia (n = 3), immune hemolytic anemia (n = 3), and Evan's syndrome (n = 3). The diagnoses were based on clinical observations, laboratory test data, and differential of other conditions. In the 12 months after splenectomy was done, the dogs reflected clinical improvement and return of platelet and/or erythrocyte counts to clinically acceptable limits; medical treatment was stopped or reduced in 8 of 9 patients. The exceptional patient had shown clinical improvement without change in the platelet count. At the end of 1 year, survival rate was excellent, and postsplenectomy complications, such as hemobartonellosis, did not appear. It is believed that splenectomy may be useful for treating immune-mediated thrombocytopenia, anemia, and Evan's syndrome that seem refractory to medication.
AuthorsB F Feldman, P Handagama, A A Lubberink
JournalJournal of the American Veterinary Medical Association (J Am Vet Med Assoc) Vol. 187 Issue 6 Pg. 617-9 (Sep 15 1985) ISSN: 0003-1488 [Print] UNITED STATES
PMID4086369 (Publication Type: Journal Article)
  • Anemia, Hemolytic (immunology, therapy, veterinary)
  • Animals
  • Cattle
  • Dog Diseases (immunology, therapy)
  • Dogs
  • Female
  • Humans
  • Male
  • Splenectomy
  • Thrombocytopenia (immunology, therapy, veterinary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: